{"id":511762,"date":"2021-07-12T08:33:33","date_gmt":"2021-07-12T12:33:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/"},"modified":"2021-07-12T08:33:33","modified_gmt":"2021-07-12T12:33:33","slug":"former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/","title":{"rendered":"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MENLO PARK, Calif., July  12, 2021  (GLOBE NEWSWIRE) &#8212; Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol, today announced that Amy Flood has joined the company as Chief Human Resources and Communications Officer.<\/p>\n<p align=\"justify\">\u201cI\u2019m very pleased to welcome Amy to our executive team,\u201d said Joseph K. Belanoff, MD, Corcept\u2019s Chief Executive Officer. \u201cShe played a key role in building the talented teams that enabled Gilead Sciences\u2019 great success. Her proven communications skills and her ability to attract, engage and retain talented employees will help us meet the challenges Corcept faces as we expand our commercial business and develop our growing portfolio of selective cortisol modulators.\u201d<\/p>\n<p align=\"justify\">Ms. Flood has nearly 25 years\u00a0of experience in team development and communications in the biotech industry. She\u00a0previously spent 21 years at Gilead Sciences, most recently as\u00a0Senior Vice President, Public Affairs, where she led a global team responsible for corporate brand, employee communications, product public relations, advocacy and philanthropy. While at Gilead she also led company-wide efforts to expand professional development opportunities for women, a targeted team mentoring and development initiative, and multiple programs focused on diversity, equity and inclusion. Prior to joining Gilead,\u00a0Amy\u00a0worked in healthcare public relations in New York, before relocating to San Francisco in 1998 to help establish her firm\u2019s west coast operations.\u00a0<\/p>\n<p align=\"justify\">\n        <strong>About Corcept Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol. Korlym<sup>\u00ae<\/sup> was the first drug approved by the U.S. Food and Drug Administration for patients with Cushing\u2019s syndrome. Corcept has discovered a large portfolio of proprietary compounds that selectively modulate the effects of cortisol. The company owns extensive United States and foreign intellectual property covering the composition of its selective cortisol modulators and the use of cortisol modulators to treat a variety of serious disorders.<\/p>\n<p align=\"justify\">\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Investor Relations<br \/>ir@corcept.com<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ipqZB4YPmxmiVDrzHJNVvQjgJS64bVzJjaBKMnwiQUYXGSbGXmnbrTDSJGyv4HFDyCOn8hnrDXFCLFv-IbX89g==\" rel=\"nofollow noopener\" target=\"_blank\">www.corcept.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/9d466948-91c4-485e-a754-6fb0951aa903\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MENLO PARK, Calif., July 12, 2021 (GLOBE NEWSWIRE) &#8212; Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol, today announced that Amy Flood has joined the company as Chief Human Resources and Communications Officer. \u201cI\u2019m very pleased to welcome Amy to our executive team,\u201d said Joseph K. Belanoff, MD, Corcept\u2019s Chief Executive Officer. \u201cShe played a key role in building the talented teams that enabled Gilead Sciences\u2019 great success. Her proven communications skills and her ability to attract, engage and retain talented employees will help us meet the challenges Corcept faces as we expand our commercial business &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-511762","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif., July 12, 2021 (GLOBE NEWSWIRE) &#8212; Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol, today announced that Amy Flood has joined the company as Chief Human Resources and Communications Officer. \u201cI\u2019m very pleased to welcome Amy to our executive team,\u201d said Joseph K. Belanoff, MD, Corcept\u2019s Chief Executive Officer. \u201cShe played a key role in building the talented teams that enabled Gilead Sciences\u2019 great success. Her proven communications skills and her ability to attract, engage and retain talented employees will help us meet the challenges Corcept faces as we expand our commercial business &hellip; Continue reading &quot;Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-12T12:33:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer\",\"datePublished\":\"2021-07-12T12:33:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/\"},\"wordCount\":361,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/\",\"name\":\"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=\",\"datePublished\":\"2021-07-12T12:33:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/","og_locale":"en_US","og_type":"article","og_title":"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer - Market Newsdesk","og_description":"MENLO PARK, Calif., July 12, 2021 (GLOBE NEWSWIRE) &#8212; Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol, today announced that Amy Flood has joined the company as Chief Human Resources and Communications Officer. \u201cI\u2019m very pleased to welcome Amy to our executive team,\u201d said Joseph K. Belanoff, MD, Corcept\u2019s Chief Executive Officer. \u201cShe played a key role in building the talented teams that enabled Gilead Sciences\u2019 great success. Her proven communications skills and her ability to attract, engage and retain talented employees will help us meet the challenges Corcept faces as we expand our commercial business &hellip; Continue reading \"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-12T12:33:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer","datePublished":"2021-07-12T12:33:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/"},"wordCount":361,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/","name":"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=","datePublished":"2021-07-12T12:33:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3ODE5OSM0MjkwODgwIzIwOTAwODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/former-gilead-sciences-executive-amy-e-flood-joins-corcept-therapeutics-as-chief-human-resources-and-communications-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=511762"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/511762\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=511762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=511762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=511762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}